J.P. Morgan 38th Annual Healthcare Conference (JPM 2020) will take place 13-16 January 2020 in San Francisco, CA, USA.

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

What is today known as the annual J.P. Morgan Healthcare Conference began in 1983 and was hosted by Hambrecht & Quist (H&Q). H&Q was acquired by Chase in 2000 and a year later Chase was acquired by J.P. Morgan. At its infancy, the conference featured just 20 companies, had about 200 attendees and focused on the biotech industry.

Today, while it is still at the Westin St. Francis in San Francisco, the annual J.P. Morgan Healthcare Conference brings thousands of investors from around the world together. The hundreds of companies presenting run the gamut, from start-ups to those with more than $300 billion in market cap, and encompass the entire global healthcare landscape, including pharmaceutical firms, healthcare service providers, profit and not-for-profits, and medical device companies.

Available on Dec 20, 2019 when JPM release officially. Schedule will be updated in next Version of MyBioGate JMP Guidebook.

Resource from Big4Bio

China Showcase, an extension of Biotech Showcase™, is just over two months away and registration is already at an all-time high. Get in on the action! Meet and network with leading China investment firms, biopharmacos and cross-border transaction experts to propel your China strategies

Since 2018, CHINA FOCUS® has been successfully held in San Francisco, Philadelphia, Boston, Vienna, and Hamburg, attracting more than 600 companies and 800 executives worldwide. It has become a name brand and the go-to event for cross-border partnership between China and the rest of the world.

Senior executives from more than 500 public & private healthcare companies across the biopharmaceuticals, IVD, medical device, and healthcare services sectors attended 2019 BFC Global Healthcare BD and Investment. More than 300 PE and VC investors from over 100 firms also attended this event in 2019. The conference will provide an optimal environment for networking with the senior executives of your potential partners. Company management teams and investors will also have the opportunity to participate in one-on-one and small group meetings through BFC Group.

Themed “Advancing Breakthroughs for Patients”, the WuXi Global Forum 2020 has a panel of 30+ esteemed industry veterans, scientific pioneers, and world-class medical practitioners. The forum will explore the most compelling subjects in our industry today, from the state of innovation in 2020 to cell and gene therapy 2.0; from the race to conquer cancer to the future of personalized healthcare.